Gulmira E. Bektenova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gulmira E. Bektenova has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Aigul Tazhiyeva
Department of Science, Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan
1 shared publication - Balnur Omarova
Department of Epidemiology, Biostatistics and Evidence-Based Medicine, al-Farabi Kazakh National University, Almaty, Kazakhstan
1 shared publication Furkhat Khatamov
Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan, Kazakhstan; and
1 shared publicationGulmira Datkayeva
Department of Pediatrics-2, South Kazakhstan Medical Academy, Shymkent, KAZAKHSTAN
1 shared publicationGulnara Ilyassova
Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkestan, Kazakhstan; and
1 shared publication- Kaldybay S. Idrissov
General Practitioner Department, South Kazakhstan Medical Academy, Shymkent
1 shared publication
Latest Publications
- Open Access
- 4 September 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (11) , 6889-6892
Comment on ‘Equipment preparedness for neonatal resuscitation in neonatal intensive care unit in resource limited setting: cross-sectional study’
An abstract is unavailable. This article is available as a PDF only.
- 4 September 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (11) , 6889-6892
Open AccessComment on ‘Equipment preparedness for neonatal resuscitation in neonatal intensive care unit in resource limited setting: cross-sectional study’
An abstract is unavailable. This article is available as a PDF only.
- 25 June 2021
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 78 (5) , e722-e728
Comparative Results of Treatment and Complications: Pedea in Open Ductus Arteriosus in Premature Infants
The open ductus arteriosus (ODA) is the vessel through which the pathological communication between the aorta and the pulmonary artery persists after birth. Clinical manifestations depend on the size of the duct and the stage of hemodynamic disorders. The course of the defect varies from asymptomatic to extremely severe. With large duct sizes, the latter manifests itself from the first week of life with signs of heart failure. The current research is devoted to the choice of the optimal method of medical and surgical treatment in premature newborns with an unaffected ductus arteriosus. Drug therapy for pulmonary hypertension is recommended only for those patients who have irreversible pulmonary hypertension. Surgical closure of the ODA is recommended for overloads of the left heart or signs of pulmonary hypertension in the presence of blood discharge from left to right and after previously suffered endocarditis. The article analyzes current information about the treatment of premature infants with ODA.
- 25 June 2021
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 78 (5) , e722-e728
Comparative Results of Treatment and Complications: Pedea in Open Ductus Arteriosus in Premature Infants
The open ductus arteriosus (ODA) is the vessel through which the pathological communication between the aorta and the pulmonary artery persists after birth. Clinical manifestations depend on the size of the duct and the stage of hemodynamic disorders. The course of the defect varies from asymptomatic to extremely severe. With large duct sizes, the latter manifests itself from the first week of life with signs of heart failure. The current research is devoted to the choice of the optimal method of medical and surgical treatment in premature newborns with an unaffected ductus arteriosus. Drug therapy for pulmonary hypertension is recommended only for those patients who have irreversible pulmonary hypertension. Surgical closure of the ODA is recommended for overloads of the left heart or signs of pulmonary hypertension in the presence of blood discharge from left to right and after previously suffered endocarditis. The article analyzes current information about the treatment of premature infants with ODA.